Activatable supramolecular photosensitizers: advanced design strategies

Mengyao Yang,Xingshu Li,Juyoung Yoon

DOI: https://doi.org/10.1039/d0qm00827c

IF: 8.6834

2021-01-01

Materials Chemistry Frontiers

Abstract:Design strategies for activatable photosensitizers (aPSs) in response to tumor-associated stimuli.

materials science, multidisciplinary,chemistry

What problem does this paper attempt to address?

Activatable Photodynamic Anticancer Photosensitizers

Bingde Zheng,Yuanyuan Zhao,Hongcai Li,Biyuan Zheng,Meirong Ke,Jiandong Huang

DOI: https://doi.org/10.7536/pc171245

2018-01-01

Progress in chemistry

Abstract:Photodynamic therapy(PDT) is a cancer therapeutic modality that utilizes photosensitizers(PSs) and molecular oxygen upon irradiation with light to generate cytotoxic reactive oxygen species leading to damage of the target tissues and cells. Activatable photosensitizers(aPSs) that are inactivated initially, can only be activated by tumor-associated stimuli, such as tumor. associated specific enzymes, acidic pH, nucleic acid, to achieve targeting diagnosis and treatment. The aPSs have become a hot spot in the field of medical photosensitizers because of its higher selectivity. In this paper, we will summarize the recent development of aPSs, and analyze their structure. activity relationships, expecting to provide a reference for the future studies.
Activatable Photosensitizers: Agents for Selective Photodynamic Therapy

Xingshu Li,Safacan Kolemen,Juyoung Yoon,Engin U. Akkaya

DOI: https://doi.org/10.1002/adfm.201604053

IF: 19

2016-01-01

Advanced Functional Materials

Abstract:Recent developments in the design of bifunctional and activatable photosensitizers rejuvenate the aging field of photodynamic sensitization and photodynamic therapy. While systematic studies have uncovered new dyes that can serve as potential photosensitizers, the most promising results have come from studies aimed at gaining precise control over the location and rate of cytotoxic singlet oxygen generation. As a consequence, higher selectivities and efficiencies in photodynamic treatment protocols are now within reach. This feature article highlights the variety of approaches that have been pursued to improve photodynamic therapy and to transform simple photosensitizers into smarter theranostic agents.
Universal Scaffold for an Activatable Photosensitizer with Completely Inhibited Photosensitivity

Wenhao Zhai,Yongkang Zhang,Ming Liu,Hao Zhang,Junqing Zhang,Changhua Li

DOI: https://doi.org/10.1002/anie.201907510

2019-01-01

Angewandte Chemie

Abstract:Activatable photosensitizers (aPSs) sensitive to specific stimuli hold potential for targeting multiple disease biomarkers and are desirable for photodynamic therapy (PDT). Presented herein is the design of aPSs that can be activated and fully recover from an inhibited state in the presence of specific biomarker. A designed long-wavelength D-π-A photosensitizer, PSSe-I , with highly efficient photosensitivity for generation of 1 O2 was used. Caging of the phenolate donor of PSSe-I with a biomarker-sensitive group provided ALP PS, and the drastic activation of its photosensitivity was demonstrated intracellularly. To enhance the flexibility of the design strategy, a clickable azide group was introduced into the scaffold to allow integration of more functionality. Modularly derived mito-PN PS, equipped with a mitochondria-targeting group and a specific peroxynitrite-reactive trigger, was synthesized and demonstrated superior performance in cells. This strategy could lead to customization of aPSs applicable to a specific PDT.
Recent advances in supramolecular activatable phthalocyanine-based photosensitizers for anti-cancer therapy

Bing-De Zheng,Jing Ye,Xue-Qin Zhang,Na Zhang,Mei-Tian Xiao

DOI: https://doi.org/10.1016/j.ccr.2021.214155

IF: 24.833

2021-11-01

Coordination Chemistry Reviews

Abstract:Phthalocyanines, as an organic compound, are widely used in photodynamic therapy (PDT), but they still have the defect of poor selectivity. By introducing the concept of activatable photosensitizers (aPSs), the selectivity and effectiveness of phthalocyanine can be improved significantly. The so-called aPSs means that phthalocyanines are inert in healthy tissues, and regulate their photoactivity through various stimulus response processes (such as pH values, GSH concentrations, enzyme existence, and so on), thus reducing the damage to normal cells. At present, a variety of phthalocyanine-based aPSs have been isolated or designed. In this review, herein, we highlight phthalocyanine-based supramolecular aPSs for PDT in the last five years, and enhance the potential in anti-cancer therapy of phthalocyanines.

chemistry, inorganic & nuclear
Smart molecular designs and applications of activatable organic photosensitizers

Eleni Nestoros,Amit Sharma,Eunji Kim,Jong Seung Kim,Marc Vendrell

DOI: https://doi.org/10.1038/s41570-024-00662-7

IF: 34.5695

2024-11-07

Nature Reviews Chemistry

Abstract:Photodynamic therapy (PDT) — which combines light, oxygen and photosensitizers (PS) to generate reactive oxygen species — has emerged as an effective approach for targeted ablation of pathogenic cells with reduced risk of inducing resistance. Some organic PS are now being applied for PDT in the clinic or undergoing evaluation in clinical trials. A limitation of the first-generation organic PS was their potential off-target toxicity. This shortcoming prompted the design of constructs that can be activated by the presence of specific biomolecules — from small biomolecules to large enzymes — in the target cells. Here, we review advances in the design and synthesis of activatable organic PS and their contribution to PDT in the past decade. Important areas of research include novel synthetic methodologies to engineer smart PS with tuneable singlet oxygen generation, their integration into larger constructs such as bioconjugates, and finally, representative examples of their translational potential as antimicrobial and anticancer therapies.

chemistry, multidisciplinary
Supramolecular photosensitizers rejuvenate photodynamic therapy.

Xingshu Li,Songyi Lee,Juyoung Yoon

DOI: https://doi.org/10.1039/c7cs00594f

IF: 46.2

2018-01-01

Chemical Society Reviews

Abstract:Owing to its spatiotemporal selectivity and noninvasive nature, photodynamic therapy (PDT) has become a clinically promising approach for the treatment of a wide range of cancers and other diseases. However, the full potential of PDT has not been achieved thus far as a consequence of the lack of optimal photosensitizers (PSs) and/or smart transport/activation strategies. These problems, which unfortunately lie at the core of the PDT paradigm, include the oxygen reliance limits, the effect of PDT on hypoxic tumors, limitations of light penetration, and undesired skin photosensitization induced by "always on" PSs. Recently, supramolecular approaches, which rely on the use of non-covalent interactions to construct biomedical active materials, have become suitable methods for developing innovative PSs. Non-covalent interactions enable supramolecular PSs to have sensitive and controllable photoactivities, important elements needed to maximize photodynamic effects and minimize side effects. In addition, versatile supramolecular PS-assemblies can be designed so that PDT occurs synergistically with other therapeutic modalities, e.g., photothermal therapy, leading to a potential improvement of therapeutic effectiveness. In this review, recent progress made in the development of supramolecular PSs for rejuvenating PDT will be presented. Importantly, this discussion also provides a view of future advances that will likely be made in this area and their potential clinical applications.
Molecular and Formulation Strategies for Photosensitizer Design

Mathias O. Senge

DOI: https://doi.org/10.1016/j.pdpdt.2024.104165

IF: 3.577

2024-05-30

Photodiagnosis and Photodynamic Therapy

Abstract:Significance Targeted delivery and selective activation of photosensitizers (PSs) is a fundamental aim in the design of photosensitizers. Ideally, the desired properties should be imprinted in the molecular structure during the design process. Approach A combination of molecular functionalization, conformational design, linking to solubilizing agents and incorporation of singlet oxygen trapping moieties was used in synthetic organic chemistry photosensitizer methods development. Results We show that: a) the molecular shape of a drug is important for cell internalization and controlling triplet state formation, b) macrocycle distortion can be used to modulate the photophysical parameters, c) singlet oxygen trapping units are suitable for controlled release of 1 O 2 , and d) that incorporation of PSs into hydrogels facilitates a PDT-induced response of the immune system. Conclusions Molecular design in organic synthesis can be used to develop new classes of photosensitizers with improved uptake, targeting, and PDT properties.

oncology
A Proton-Activatable Aminated-Chrysophanol Sensitizer for Photodynamic Therapy

Yana Bian,Mingle Li,Jiangli Fan,Jianjun Du,Saran Long,Xiaojun Peng

DOI: https://doi.org/10.1016/j.dyepig.2017.08.029

IF: 5.122

2017-01-01

Dyes and Pigments

Abstract:Exploiting the tumor microenvironment provides a new strategy for cancer treatment. In order to develop the microenvironment-selective photosensitiser, we rationally designed a proton-activatable aminated-chrysophanol derivative-compound 3, which combines fluorescence and reactive oxygen species regulated by the tumor acidic microenvironment for the first time. Furthermore, two PET tertiary amine substituents introduced by compound 3 enhance the cellular uptake, prolong the wavelength of the absorption, and increase the phototoxicity. Not only can compound 3 distinguish the cancer cells from normal cells but also the tumor from the normal tissue by the higher fluorescence intensity in cancer cells and tissues. Additionally, lysosome destruction test proves cell necrosis in lysosomal related pathway. We believe that the proton-activatable photosensitiser modulated by tumor acidic microenvironment offers a good chance for the cancer treatment in clinic.
Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy

Ming Liu,Changhua Li

DOI: https://doi.org/10.1002/cplu.202000203

2020-01-01

ChemPlusChem

Abstract:Photodynamic therapy is an alternative modality for the therapy of diseases such as cancer in a minimally invasive manner. The essential photosensitizer, which acts as a catalyst when absorbing light, converts oxygen into cytotoxic reactive oxygen species that ablate malignant cells through apoptosis and/or necrosis, destroy tumor microvasculature, and stimulate immunity. An activatable photosensitizer whose photoactivity could be turned on by a specific disease biomarker is capable of distinguishing healthy cells from diseased cells, thereby reducing off‐target photodamage. In this Minireview, we highlight progress in activatable organic photosensitizers over the past five years, including: (i) biorthogonal activatable BODIPYs; (ii) activatable Se‐rhodamine with single‐cell resolution; (iii) silicon phthalocyanine targeting oxygen tension; (iv) general D‐ π ‐A scaffolds; and (v) AIEgens. The potential challenges and opportunities for developing new types of activatable organic photosensitizers to overcome the hypoxia dilemmas of photodynamic therapy are discussed.
Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment

Xuehong Min,Fan Yi,Xiao-Le Han,Ming Li,Qianci Gao,Xiaocui Liang,Zhao Chen,Yue Sun,Yi Liu,Xuehong Min,Fan Yi,Xiao-Le Han,Ming Li,Qianci Gao,Xiaocui Liang,Zhao Chen,Yue Sun,Yi Liu

DOI: https://doi.org/10.1016/j.cej.2021.134327

IF: 15.1

2022-03-01

Chemical Engineering Journal

Abstract:Aggregation-induced emission (AIE)-active photosensitizers (PSs) are considered as a kind of promising functionalized materials for photodynamic therapy of tumor. Improving the targeted ability of water-soluble AIE PSs capable of minimizing the inadvertent activation is of great significance but remains a challenging task. Herein, we report an effective synthetic strategy for preparing water-soluble AIE photosensitizer (termed WAPS) with high targeted capacity mediated by supramolecular assembly. The pillar[5]arene (WP5) can bind WAPS through host–guest interaction in neutral aqueous solution, resulting in a large change in donor–acceptor structure of WAPS and a weak photodynamic activity. Notably, the binding interface of WAPS and WP5 shifts under an acidic environment (pH 5.2), permitting the reversible control of singlet oxygen (1O2) generation and photodynamic targeting of cancer cells in cultured and tumor-bearing mice. This work provides an ingenious way to prepare water-soluble AIE PS with high selectivity for tumor treatment.

engineering, chemical, environmental
A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal in Vivo Skin Phototoxicity.

Xingshu Li,Bi-Yuan Zheng,Mei-Rong Ke,Yongfan Zhang,Jian-Dong Huang,Juyoung Yoon

DOI: https://doi.org/10.7150/thno.18861

IF: 11.6

2017-01-01

Theranostics

Abstract:A major challenge in photodynamic therapy (PDT) is the development of new tumor-targeting photosensitizers. The tumor-specific activation is considered to be an effective strategy for designing these photosensitizers. Herein, we describe a novel tumor-pH-responsive supramolecular photosensitizer, LDH-ZnPcS8, which is not photoactive under neutral conditions but is precisely and efficiently activated in a slightly acidic environment (pH 6.5). LDH-ZnPcS8 is prepared by using a simple coprecipitation method based on the electrostatic interaction between negatively charged octasulfonate-modified zinc(II) phthalocyanine (ZnPcS8) and cationic hydroxide layers of layered double hydroxide (LDH). The in vitro photodynamic activities of LDH-ZnPcS8 in cancer cells are dramatically enhanced relative to those of ZnPcS8 alone. The results of in vivo fluorescence imaging demonstrate that the nanohybrid is activated in tumor tissues, where it displays an excellent PDT effect resulting in 95.3% tumor growth inhibition. Furthermore, the minimal skin phototoxicity of LDH-ZnPcS8 highlights its high potential as a novel photosensitizer for activatable PDT.
Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy

Jucai Gao,Yu Tian,Yonggang Li,Fang Hu,Wenbo Wu

DOI: https://doi.org/10.1016/j.ccr.2024.215756

IF: 24.833

2024-01-01

Coordination Chemistry Reviews

Abstract:Photodynamic therapy (PDT) is emerging as a powerful tool in tumor treatment due to its unique advantages of being minimally invasive and universally applicable. Photosensitizers (PSs) play a crucial role in PDT, and those with aggregation-induced emission (AIE) have been developed to enhance fluorescence and improve photosensitization under physiological conditions for image-guided PDT. However, the non-specific distribution of PSs during PDT and their prolonged retention in the body after PDT can result in damage to normal tissues upon exposure to light, leading to the occurrence of severe side effects. Therefore, this review systematically summarized the latest advances in designing new AIE PSs to enhance the safety of PDT. In particular, some strategies of targeted PSs, responsive turn-on PSs, and two-photon excitable PSs to enhance the intraoperative safety, as well as the strategy of degradable PSs to enhance the postoperative safety were focused.
Author Response for "A E/Z Isomers Strategy of Photosensitizers with Tunable Generation Processes of Reactive Oxygen Species"

Xiaochun Liu,Hairong Li,Hui Tang,Ning Ma,Shiyu Wu,Wenbo Dai,Yahui Zhang,Xiao-Qi Yu

DOI: https://doi.org/10.1039/d4tc03028a/v2/response1

2024-01-01

Abstract:Designing Type I photosensitizers (PSs) with ease and precision is a promising approach to address the limitations of traditional photodynamic therapy (PDT) within the hypoxic tumor microenvironment. An effective strategy...
An Acceptor-Shielding Strategy of Photosensitizers for Enhancing the Generation Efficiency of Type I Reactive Oxygen Species and the Related Photodynamic Immunotherapy

Jiamin Qu,Yahui Zhang,Zhengxu Cai,Bin Tong,Haiyan Xie,Yuping Dong,Jianbing Shi

DOI: https://doi.org/10.1039/d2nr02273g

IF: 6.7

2022-01-01

Nanoscale

Abstract:Developing efficient photosensitizers (PSs) that can generate type I reactive oxygen species (ROS) under illumination is considered an effective way to improve photodynamic therapy (PDT) outcomes due to the hypoxic nature of the tumor environment, but also is very challenging. Herein, a new PS of the multiarylpyrrole (MAP) derivative with a typical donor-acceptor structure was synthesized to efficiently generate type I ROS by using an acceptor-shielding strategy in their aggregated state. The enhanced generation mechanism of type I ROS originated from its ultralong triplet lifetime and the narrow singlet-triplet energy gap of the MAP. More importantly, type I ROS can transform protumoral M2 macrophages (M2) into antitumoral M1 macrophages (M1), which showed synergistic immunotherapy in in vivo experiments. Therefore, introducing shielding groups into acceptors provides general guidance for developing efficient PSs in the aggregation state for clinical PDT.
Recent Molecular Design Strategies for Efficient Photodynamic Therapy and Its Synergistic Therapy Based on AIE Photosensitizers

Jinxi Liu,Wenting Chen,Caiyun Zheng,Fangfang Hu,Jiabao Zhai,Que Bai,Na Sun,Gao Qian,Yanni Zhang,Kai Dong,Tingli Lu

DOI: https://doi.org/10.1016/j.ejmech.2022.114843

IF: 7.088

2022-01-01

European Journal of Medicinal Chemistry

Abstract:Cancer seriously endangers human life and health. Recently, the development of AIEgens with aggregation-induced emission (AIE) effect as a new generation of photosensitizers (PSs) to circumvent aggregation-induced fluorescence quenching and reduction of ROS generation has received extensive attention in photodynamic therapy (PDT), a non-invasive anticancer therapy. Rational molecular design can enhance the photosensitization of AIE PSs to achieve effective PDT and can realize the construction of functionalized AIE PSs and synergistic therapy based on AIE PSs. To improve the efficacy of AIE PSs for cancer treatment, many groups have conducted molecular design studies and produced exciting results. This review summarizes the molecular design strategies of three types of AIE PSs for effective photodynamic therapy, focusing on the design strategies of pure organic small molecule type AIE PSs, and reviews the existing design strategies of metal complexes and conjugated polymers. Subsequently, the design strategy to achieve synergistic treatment of AIE PSs from molecular modifications is summarized. The challenges and prospects of the AIE PSs research field are further discussed.
Redox-activated Photosensitizers for Visualizing Precise Diagnosis and Potentiating Cancer Therapy

Shuwen Fu,Zixuan Chen,Li,Yinwei Wu,Yalan Liao,Xingshu Li

DOI: https://doi.org/10.1016/j.ccr.2024.215734

IF: 24.833

2024-01-01

Coordination Chemistry Reviews

Abstract:Cancer still threats human health rigorously. Most current options of photosensitizers (PSs) are plagued with "always on", accounting for limited signal-to-noise ratio in the lesions and undesired side effects in normal tissues. Inspired by the redox imbalance of tumor microenvironment, redox-activated PSs (RA-PSs) are coming to frontiers that enhance diagnosis accuracy and treatment efficiency. Herein, the progress of PSs-based therapy is outlined. Furthermore, the design strategies of RA-PSs are discussed, including potential mechanism and linkage to obtain on-demand switchable optical signals. Moreover, versatile RA-PSs for real-time visualization and therapy are highlighted. Finally, future prospects and challenges are spotlighted.
Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells

Bin Yuan,Hua Wang,Jiang-Fei Xu,Xi Zhang

DOI: https://doi.org/10.1021/acsami.0c07471

IF: 9.5

2020-01-01

ACS Applied Materials & Interfaces

Abstract:Photodynamic therapy (PDT) is a promising approach for the treatment of different kinds of cancers as well as some other diseases. By combining spatiotemporal light irradiation with photosensitizers (PS), PDT can be easily controlled by tuning illumination time and sites of irradiation. However, how to reduce the phototoxicity of the PS to normal cells without sacrificing its effectiveness to cancer cells is still a challenge. Herein, we put forward a deactivation and reactivation strategy for PDT to reduce the undesired damage to normal cells under light irradiation. First, by chemical modification of meso-(4-pyridinyl)-substitution BODIPY with phenylboronic acid pinacol ester moiety, the masked PS ProBODIPY-2I with low generation efficiency of singlet oxygen and good water solubility can be obtained. Moreover, ProBODIPY-2I can be reactivated at tumor microenvironment by reactive oxygen species (ROS), resuming their PDT efficiency. Meanwhile, ProBODIPY-2I showed low phototoxicity for the normal cells, due to the relatively low concentration of ROS. In this way, the safety and selectivity for the PDT can be greatly improved. It is anticipated that some other tumor biomarkers, such as proton, GSH and enzymes, can be employed for the smart PDT methods.
A Facile Supramolecular Strategy to Switch Photodynamic Pathway and Augment ROS Production of Sensitizers for Enhanced Tumor Therapy

zhiliang li,Kirk Schanze,fengling song,Ruihua Guo,Han Sun,habtom gobeze,Kanyashree Jana,yingnan wu

DOI: https://doi.org/10.26434/chemrxiv-2024-cl4pc

2024-07-02

Abstract:The photosensitizers (PSs) capable of generating radical reactive oxygen species (ROS) via the type-I electron transfer pathway under photoirradiation offer a promising solution to the challenge of unsatisfactory photodynamic therapy (PDT) in hypoxic environments. Classical PSs (type-II), however, primarily transfer excited energy to ground state O2 rather than undergoing photoinduced electron transfer, posing a tough challenge in promoting the type-I pathway through existing strategies. Herein, we demonstrate a novel and straightforward approach using bioinspired supramolecular assembly to convert classical type-II PSs into type-I supramolecular PSs with augmented ROS production. The phosphate-templated assembly facilitated the formation of nanoscale aggregates with orderly and efficient packing of PSs, effectively suppressing the energy transfer pathway by promoting photoinduced charge- separation between PSs (resulting in PS+· and PS−·), thereby enhancing the generation of superoxide radicals (O2−·) through electron transfer from PS−· to O2 (Scheme 1). Additionally, this shift of photosensitization pathway also enhances overall ROS production, overcoming the typical inhibition usually associated with PS aggregation and indicating the highly efficient ROS generation via the type-I pathway. Consequently, the type-I supramolecular PSs demonstrated excellent ROS generation capability in the treatment of hypoxic tumors, thus achieving outstanding therapeutic outcomes. This study not only addresses a critical challenge in PDT under hypoxic conditions but also opens a new avenue for modifying the sensitization behavior of clinically approved type-II PSs to achieve superior therapeutic outcomes.

Chemistry
Aggregation-Induced Emission Photosensitizers: from Molecular Design to Photodynamic Therapy.

Jun Dai,Xia Wu,Siyang Ding,Xiaoding Lou,Fan Xia,Shixuan Wang,Yuning Hong

DOI: https://doi.org/10.1021/acs.jmedchem.9b02014

IF: 8.039

2020-01-01

Journal of Medicinal Chemistry

Abstract:Photodynamic therapy (PDT) has emerged as a promising noninvasive treatment option for cancers and other diseases. The key factor that determines the effectiveness of PDT is the photosensitizers (PSs). Upon light irradiation, the PSs would be activated, produce reactive oxygen species (ROS), and induce cell death. One of the challenges is that traditional PSs adopt a large flat disc-like structure, which tend to interact with the adjacent molecules through strong p-p stacking that reduces their ROS generation ability. Aggregation-induced emission (AIE) molecules with a twisted configuration to suppress strong intermolecular interactions represent a new class of PSs for image-guided PDT. In this Miniperspective, we summarize the recent progress on the design rationale of AIE-PSs and the strategies to achieve desirable theranostic applications in cancers. Subsequently, approaches of combining AIE-PS with other imaging and treatment modalities, challenges, and future directions are addressed.
Donor-Acceptor Engineering for Tailoring Highly Efficient Photosensitizers for Image-Guided Antitumor Photodynamic Therapy

Edward Kamya,Shangzhao Yi,Zahid Hussain,Zhongzhong Lu,Wenjing Li,Jincong Yan,Fanshu Ma,Ismat Ullah,Yi Cao,Renjun Pei

DOI: https://doi.org/10.1021/acsmacrolett.3c00500

IF: 5.8

2023-11-04

ACS Macro Letters

Abstract:Photosensitizers (PSs) have greatly flourished as a promising tool for photodynamic therapy owing to their integration of both in situ diagnosis and treatment in a single nanoplatform. However, there is still a need to explore synthesis pathways that can result in high-performance PSs with good reproducibility, high yield, less dark toxicity, and an attractive therapeutic index. Therefore, by exploiting the precise molecular engineering guideline, this work unveils a straightforward protocol to...

polymer science

Activatable supramolecular photosensitizers: advanced design strategies

Activatable Photodynamic Anticancer Photosensitizers

Activatable Photosensitizers: Agents for Selective Photodynamic Therapy

Universal Scaffold for an Activatable Photosensitizer with Completely Inhibited Photosensitivity

Recent advances in supramolecular activatable phthalocyanine-based photosensitizers for anti-cancer therapy

Smart molecular designs and applications of activatable organic photosensitizers

Supramolecular photosensitizers rejuvenate photodynamic therapy.

Molecular and Formulation Strategies for Photosensitizer Design

A Proton-Activatable Aminated-Chrysophanol Sensitizer for Photodynamic Therapy

Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy

Targeted photodynamic therapy using a water-soluble aggregation-Induced emission photosensitizer activated by an acidic tumor microenvironment

A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal in Vivo Skin Phototoxicity.

Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy

Author Response for "A E/Z Isomers Strategy of Photosensitizers with Tunable Generation Processes of Reactive Oxygen Species"

An Acceptor-Shielding Strategy of Photosensitizers for Enhancing the Generation Efficiency of Type I Reactive Oxygen Species and the Related Photodynamic Immunotherapy

Recent Molecular Design Strategies for Efficient Photodynamic Therapy and Its Synergistic Therapy Based on AIE Photosensitizers

Redox-activated Photosensitizers for Visualizing Precise Diagnosis and Potentiating Cancer Therapy

Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells

A Facile Supramolecular Strategy to Switch Photodynamic Pathway and Augment ROS Production of Sensitizers for Enhanced Tumor Therapy

Aggregation-Induced Emission Photosensitizers: from Molecular Design to Photodynamic Therapy.

Donor-Acceptor Engineering for Tailoring Highly Efficient Photosensitizers for Image-Guided Antitumor Photodynamic Therapy